Belmont Global Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	$1.02M	Buy	+15,000	New	+$1.02M	0.96%	14
2014 Q3	–	Sell	-6,500	Closed	-$411K	–	119
2014 Q2	$411K	Buy	+6,500	New	+$411K	0.3%	85